Next Article in Journal
Assessment of Ab Initio and Density Functional Theory Methods for the Excitations of Donor-Acceptor Complexes: The Case of the Benzene-Tetracyanoethylene Model
Next Article in Special Issue
A Novel Action of Endocrine-Disrupting Chemicals on Wildlife; DDT and Its Derivatives Have Remained in the Environment
Previous Article in Journal
The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: The Role of HO-1
Previous Article in Special Issue
Contributions of Bioactive Molecules in Stem Cell-Based Periodontal Regeneration
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Allosteric Activation of GDP-Bound Ras Isoforms by Bisphenol Derivative Plasticisers

1
Faculty of Chemistry and Biochemistry, Ruhr University of Bochum, Universitätsstr. 150, D-44780 Bochum, Germany
2
Skin Cancer Unit of the Dermatology Department, West German Cancer Center, University Hospital Essen, University Duisburg-Essen and the German Cancer Consortium (DKTK), D-45147 Essen, Germany
3
Institute of Pharmacology and Toxicology, Witten/Herdecke University, Stockumer Str. 10, D-58453 Witten, Germany
4
Faculty of Mathematics and Natural Sciences, University of Wuppertal, Gaußstr. 20, D-42119 Wuppertal, Germany
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(4), 1133; https://doi.org/10.3390/ijms19041133
Submission received: 27 February 2018 / Revised: 4 April 2018 / Accepted: 5 April 2018 / Published: 10 April 2018
(This article belongs to the Special Issue Advances in the Research of Endocrine Disrupting Chemicals)

Abstract

:
The protein family of small GTPases controls cellular processes by acting as a binary switch between an active and an inactive state. The most prominent family members are H-Ras, N-Ras, and K-Ras isoforms, which are highly related and frequently mutated in cancer. Bisphenols are widespread in modern life because of their industrial application as plasticisers. Bisphenol A (BPA) is the best-known member and has gained significant scientific as well as public attention as an endocrine disrupting chemical, a fact that eventually led to its replacement. However, compounds used to replace BPA still contain the molecular scaffold of bisphenols. BPA, BPAF, BPB, BPE, BPF, and an amine-substituted BPAF-derivate all interact with all GDP-bound Ras-Isoforms through binding to a common site on these proteins. NMR-, SOScat-, and GDI- assay-based data revealed a new bisphenol-induced, allosterically activated GDP-bound Ras conformation that define these plasticisers as Ras allosteric agonists.

Graphical Abstract

1. Introduction

In order for cells to respond to their external microenvironment, proper cell signalling is pivotal. Small GTPases, such as (H-, N-, and K-) Ras and Ras homologue enriched in the brain (Rheb), are crucial members of Ras superfamily of guanine nucleotide-binding proteins [1]. Ras—a known proto-oncogene—carries mutations in more than 20% of human cancers, like pancreatic, colon, and lung carcinomas [2]. Ras and Rheb are small GTPases and, as such, they are able to bind and hydrolyse guanosine triphosphate (GTP) to guanosine diphosphate (GDP). This reaction, often regarded as their physiological hallmark, enables these small GTPases to switch between an active or GTP-bound-state and a GDP-bound state that is inactive. The activation/inactivation GTP/GDP cycle of all Ras-like G-proteins is not only negatively regulated by GTPase activating proteins (GAPs) but also positively influenced by guanine nucleotide exchange factors (GEFs) [3]. These proteins, such as the son of sevenless (Sos) protein and RasGRP1, interact directly with G-proteins and lower the affinity of these (Ras-like) G-proteins for its bound nucleotide [3,4]. The Sos protein catalyses the rate-limiting and thus important step of restoring the level of activated, GTP-bound K-Ras4B in the cell, an essential protein isoform of the ras gene family members [3]. Thus, the transition between these two GTPase states is catalysed by guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs) enhancing the intrinsic rate of GTP hydrolysis by small GTPases. Taken together, the GTPase cycle comprises inactive, GDP-bound and active, GTP-bound states that transmit extracellular within cells by interacting with numerous intracellular effector proteins. Therefore, this regulatory mechanism enables small GTPases to function as molecular switches in living cells. These key players of the intracellular signalling cascade have been in the focus of numerous cancer drug development initiatives for the more than two decades now [5,6,7,8].
Previously, we have identified 4,4′-biphenol and Bisphenol A (BPA) as novel small molecular weight ligands for Rheb and K-Ras, respectively [9]. We have also shown that Bisphenol A (BPA)—but not Bisphenol S (BPS)—can interfere with the GEF-mediated nucleotide exchange from GDP to GTP [10]. Our study revealed for the first time that the plasticiser Bisphenol A is a K-Ras4B ligand, suggesting an entirely new mode of action for this endocrine disrupting chemical (EDC) and thereby supplementing the well-established estrogen receptor proteins as molecular targets of bisphenols [9]. Chemically, the family of bisphenols is characterised by an optionally substituted central carbon atom that is substituted by two hydroxyphenyl moieties. The most common member of this family is Bisphenol A (BPA, 4,4′-(propane-2,2-diyl)diphenol, CAS 80-05-7), whose central carbon carries two methyl and two phenolic groups. This compound class is in the center of both scientific and public discussion as to whether it can unsettle the normal activity of hormone receptors, because Bisphenol A is one of the chemicals humans are most frequently exposed to on a daily basis [11]. Food containers made out of polycarbonate plastics, such as baby bottles, and documents printed on thermal paper contain Bisphenol A, to name but a few [11]. Bisphenol A is suspected to cause cardiovascular diseases, breast and prostate cancers as well as neuronal disorders [11]. Bisphenol A has lately been replaced by its chemical analogue Bisphenol S (4,4′-Sulphonyldiphenol, CAS 80-09-1) due to public pressure and new governmental restrictions [10]. Yet, as previously found for BPA, BPS binds—albeit with a lower affinity—to a small ligand binding site between switch I and switch II of K-Ras4B, which is close to helix α2 and the core β-sheets (β1–β3) [10]. However, in sharp contrast to Bisphenol A, Bisphenol S cannot interfere with the Sos-meditated nucleotide exchange of K-Ras4B.
Therefore, we have conducted a comprehensive study of the interaction between common bisphenol compounds and the Ras isoforms H-Ras, N-Ras, and K-Ras, in order to gain a more complete picture of the impact bisphenol compounds can pose on these small GTPases (Table 1 and Table S1). Here, we now show for the first time that bisphenolic molecules bind to Ras isoforms in their GDP-bound state and induce a change into their active conformation in an allosteric manner. To our knowledge, this is the first study of low molecular weight ligands that induce the active form of Ras GTPases, thereby triggering their signalling cascades in a GTP-independent manner. These results pave the way for the future development of small molecules that can act as GTPase modulators that could switch GTPase-triggered signalling cascades in the cell on or off. Consequently, we believe that food safety investigations should devote more attention to bisphenol derivatives and go beyond well-established receptor studies for two main reasons. Firstly, GTPases are important off-target proteins that can be activated and then trigger their respective signalling cascades—an issue not considered so far. Secondly, the bisphenol scaffold could serve as a blueprint for low molecular weight GTPase ligands, allowing for an activation of signalling cascades that could ultimately modulate cellular responses. Up to now, various Ras-ligands are known, which bind directly to different pockets [12]. Some of these molecules bind to a pocket between switch I and switch II [5,6,7,13] and we could previously show that not only BPA but also BPS binds to GDP-bound K-Ras4B [9,10]. Furthermore, BPA, but not BPS, interferes with the protein-protein interaction between K-Ras4B and its GEF Son of Sevenless (SOS). Here, in a “structure-activity-relationship (SAR) by NMR”-like approach, we tested 14 different bisphenols, which all vary in their bridging moiety flanked by two phenolic groups. (Table 1 and Table S1).

2. Results

AFX [4-(Trifluoromethyl)phenol] was tested in order to evaluate the effect of a single ring ligand on K-Ras4B (Table 1). Using multi-dimensional NMR spectroscopy, we detected significant chemical shift perturbations (CSPs) induced by AFX for amino acids L6, I55, L56, D57, T74, and G75 of 15N isotopically-enriched K-Ras4B. However, a KD value could not be determined precisely (KD > 50 mM). Next, we tested the simplest structural bisphenolic ligand, which is BPF carrying two hydrogens instead of two methyl groups in BPA located outside the AFX binding pocket of K-Ras4B, followed by other bisphenol derivatives (Table 1 and Table S1). Interestingly, amino acids that experienced CSPs were, in part, neither surface-exposed, nor close to the AFX binding pocket. Based on their location in the canonical GTPase fold, the affected residues can be grouped into three clusters (Figure 1).
The first cluster comprises amino acids that contact the first phenyl ring of BPA (L6, I55, L56, T74, G75). The second cluster mainly consists of hydrophobic residues (V7, V8, V9, L79/C80, I93), which sense the ligand binding information indirectly through L6. Thirdly, the nucleotide binding domain (NBD)-cluster is made of the amino acids G10, G13, D57, and G60 that are triggered by the interaction between the amide group of L56 and the ligand. The same binding pattern for these three clusters is also observed for BPE, which contains one hydrogen atom and one methyl group at the central carbon atom and exhibits a KD of 6.5 ± 0.7 mM. Bearing two CH3 groups, BPA yields a KD of 0.6 ± 0.2 mM [9] and mainly exhibits the same pattern as observed for BPF and BPE. In the case of BPB, which contains one methyl and one ethyl substitution, we observed a deterioration of the KD to 3.6 ± 0.7 mM. Apparently, the ethyl group is sterically too demanding and prevents the exact ring phenyl orientation required for tighter binding. This observation is in agreement with previously published results for BPS [10]. Substituting protons with fluorine has been shown to potentially alter molecular conformation and to specifically enhance affinity for proteins [14]. In line with these observations, the presence of two fluoromethyl groups in BPAF yields a slightly lower KD value of 0.35 ± 0.02 mM (Table 1 and Table S1; Figures S1–S4).
Since BPAF exhibits the largest affinity for K-Ras4B, we tested as to whether BPAF could antagonise the interaction between K-Ras4B and SOScat. Thus, we carried out a titration of 14N SOScat to 15N-K-Ras4B to create a complex of around 80 kDa, which leads to a broadening of NMR resonances presumably due to rotational correlation effects. This can be observed at a 1:1 ratio and is further pronounced when more SOScat is added (Figure 2 and Figure S3).
When BPAF was titrated to this complex, previously vanished resonances could be recovered at the frequencies specific for the bisphenol-bound K-Ras4B protein. Thus, BPAF can antagonise the interactions between GDP-bound K-Ras4B and SOScat. Molecular dockings using the HADDOCK software suite [15] suggest that BPAF binds at the interface of SOScat and K-Ras4B and sterically antagonises Ras/SOScat protein complex formation, neighbouring amino acids Y64, M67, and Y71 that are known as the hydrophobic anchor of the Ras-SOScat-interaction [16]. Additionally, reorganisation of switch II is fundamental to the interaction between K-Ras4B and SOScat [16], and both mechanisms are apparently affected by BPAF binding. Since Ras isoforms share a high sequence similarity, we also tested H-Ras and N-Ras for their potential to interact with BPAF. For H-Ras and BPAF, a similar pattern of CSPs was observed and the NMR-based titration experiment yielded a KD of 0.40 ± 0.02 mM. For N-Ras (1-170), we also observed a similar pattern of CSPs. In addition, the KD was in the same range (0.77 ± 0.02 mM). These results show that all three Ras-isoforms interact equally with BPAF and that, at least for H-Ras and K-Ras4B, the HVR-region does not affect binding of BPAF. Rap-1A, which shares a sequence similarity of 50% with Ras, was also tested. It is known, that the Ras/Rap effector specificity is determined by charge reversal [17]. When Rap-1A was titrated with BPAF, CSPs up to a BPAF concentration of 5 mM could not be detected (Figure S2). Obviously, numerous changes of binding pocket residues (for example T74 to N74) prevent Rap-1A from binding to BPAF, in accordance with GTPase-effector specificity. Apparently, BPAF is able to select K-Ras4B, H-Ras, and—to a slightly lesser extent—N-Ras over Rap-1A. Noteworthy, Ras-family members, such as H-Ras, Rap-1A, and R-Ras, exhibit different affinities over a broad range towards the effector molecules c-Raf kinase and Ral guanine nucleotide exchange factor (RGF), for instance [17,18]. The aromatic phenyl rings of the BPAF analogue BPNH2 are amino-substituted at the meta-position and when titrated to K-Ras4B, an intermediate-exchange of resonances for the binding pocket residues (L56, D57, T74, and G75) was observed at 600 MHz 1H Larmor frequency, contrary to a fast exchange detected for BPAF. This indicates a change in binding kinetics (Figure 3). In addition, the NBD cluster (G10, G13, D57, and G60) exhibits line broadening of NMR resonances. Threonine 35, an amino acid which is next to G60 and fundamental to the loaded spring model [19], exhibits a change in chemical environment that corresponds to fast/intermediate exchange upon ligand binding.
Furthermore, we performed SOScat-catalysed guanine nucleotide exchange (SOScat-assay) and guanine nucleotide dissociation (GDI-) assays, that both exploit the protein-bound fluorescent mant-nucleotide [20]. The underlying mechanism of the SOScat-assay is that mant-GDP is exchanged by non-fluorescent GDP in the presence of Ras-GEF SOScat. By varying the BPNH2 concentration, a KD of 0.20 ± 0.10 mM could be extracted from this SOScat-assay (Figure 4). This KD value for BPNH2 is slightly lower than for BPAF, which can be attributed to the amino groups as hydrogen bond donors [21].
Additionally, we performed a GDI-assay that observes inhibition of nucleotide dissociation [18,20] (Figure S7). Hitherto, this method was used to measure complex formation between Ras and its effectors. Surprisingly, while BPAF showed no or only a very small effect, BPNH2 exhibited a significant GDI-effect with a KD value of 0.34 ± 0.02 mM, which is in good agreement with the value derived from the SOScat-assay and the NMR experiments (Figure 3, Figure 4 and Figures S1 and S7; Table 1 and Table S1). Taken together, these three independent biophysical and biochemical assays show that both BPNH2 and BPAF interfere with the SOScat mediated nucleotide exchange, but only BPNH2 exhibits a functional GDI effect on K-Ras4B (Figure 4 and Figure S7). Consequently, the characteristic line broadening of the NBD cluster resonances and the inhibition of intrinsic nucleotide release are caused by the introduction of amino groups at both phenolic moieties. It is interesting to note that the characteristic line broadening for switch I and II of GppNHp-loaded GTPase caused by micro- to millisecond dynamics does not occur for GDP-bound K-Ras4B when complexed with a bisphenolic compound. Apparently, the amide resonances of the switch regions in the GDP/K-Ras4B complex experience fast rather than intermediate exchange upon binding of bisphenols (Figure 5). The amide resonance intensity of Y157 from Ras-GTP is known to gradually decline while the corresponding resonance from Ras-GDP increases accordingly as GTP hydrolysis proceeds [22]. The proton-amide chemical shift of Y157 clearly shows that the compounds gradually shift the conformational equilibrium via intermediate positions from the resonance of the inactive to the active form (Figure 5).
The amide resonances of residues I24, Q25, D57, G75, A83, I84, N86-S89, H94, G115, C118, Q129-Q131, I139, S145, T148, and F156-T158 in K-Ras4B bound to GDP experience chemical shift perturbations towards resonance frequencies of K-Ras4B bound to GppNHp upon binding of BPAF (Figure 5 and Figure S5). These residues are not located close to the BPAF binding pocket of K-Ras4B but cluster around the switch I and II regions, the region next to the bound GDP as well as neighbouring helices (Figure 5). This suggest that binding of BPAF to GDP-loaded K-Ras4B allosterically induces to a certain extent a conformation that resembles the active, GppHp-bound form of K-Ras4B. Quantitatively, BPNH2 binding shifts the amide NMR resonance of Y157 to approx. 64% of the Y157 resonance frequency in the active, GppNHp-bound state (Figure S6). For the saturated BPAF-, BPA-, and BPS-protein complex this effect is less pronounced at 58%, 49%, and 20%, respectively. We note that these different levels of allosterically activated GDP-bound K-Ras4B induced by bisphenols correlate reasonably well with KD values determined by NMR and IC50 values extracted from a MTT assay (Figure 5 and Figures S6 and S7). More interestingly, a vector-based analysis of CSP induced by bisphenols for amide-nitrogen and amide-proton NMR resonances of M67 and, in particular, T74 reveals a correlation between CSP and the affinity as well as the agonistic potential of bisphenols, notably BPAF and BPNH2 (Figure S5). Located in close proximity to the second phenyl ring of bisphenols, these resonances can act as sensors to predict the binding potential of low molecular weight compounds. Thus, this vector-based analysis of CSP might greatly facilitate the identification and discrimination of additional Ras agonists in the future. In order to test the agonistic effect of BPs on Ras in vivo under physiological conditions, we carried out a G-LISA Ras activation assay (Figure 6). Interestingly, the stimulation of HEK293T cells with BPAF revealed a significant and time-dependent augmentation of Ras activity. In addition, western blotting was performed to test as to whether BPNH2 and BPAF could activate c-Raf kinase and/or PI3K signalling via phosphorylating ERK and/or AKT kinase(s), respectively (Figure 6). On the one hand, BPAF increased the level of ERK phosphorylation, whereas BPNH2 failed to activate the Ras signalling pathway via c-Raf kinase. On the other hand, while BPAF leads to slightly elevated levels of phosphorylated AKT kinase (pAKT) after 2 h, pAKT can clearly be detected already after 1 h of exposing HEK293T cells to BPNH2.

3. Discussion

Taken together, we observe for all bisphenols tested in this study, ranging from BPF to BPNH2, direct binding to a well-characterized binding pocket between Switch I and Switch II and an allosteric effect on the NBD of K-Ras4B. However, only for BPNH2 do we observe line broadening for the NBD residues G10, G13, and G60 (Figure 3). Also, T35 exhibits similar chemical shift perturbation changes upon titrating BPNH2 to K-Ras4B. This line broadening was not observed for the switch regions, what would be a direct indicator for active K-Ras4B. In addition, BPNH2 executes a GDI effect on K-Ras4B and binding of SOS to the BPNH2-Ras(GDP)-complex is impaired (Figure 4 and Figure S7). Ras adopts at least two main conformational states in accordance to the binary switch on/off-model. In the triphosphate-bound conformation of Ras, at least two states, termed T1/T2, exist. Remarkably, only T2 is capable of binding to effectors [23]. Furthermore, the GDP-bound form of Ras is characterised by heterogeneous states, denoted as polysterism [24]. We hypothesise that binding of bisphenolic ligands to K-Ras4B alter its conformational ensemble while still bound to GDP, favouring a state in-between the active and inactive one. Our NMR data clearly show that BPAF can antagonise the GDP-bound K-Ras4B/SOScat interaction and that bisphenols act as non-covalent allosteric agonists on GDP-bound Ras (Figure 1, Figure 2 and Figure 5). This agonistic effect of bisphenols on Ras in vivo under physiological conditions is corroborated by G-LISA Ras activation assay and western blot analysis, respectively (Figure 6). Taken together, BPAF can activate the c-Raf kinase pathway and partly PI3K signalling whereas BPNH2 only acts on the latter under physiological conditions in HEK293T cells. This is presumably achieved by utilising the different affinities over a broad range of Ras-family members towards their effector molecules [18,25]. It is interesting to note that a similar yet not identical mechanism of activation has also been observed for other small GTPases, e.g., Rab1b, a main regulator of membrane trafficking [26]. Unlike the non-covalent allosteric agonistic mode of action of bisphenols on Ras, Rab1b is covalently AMPylated by the Legionella effector protein DrrA at tyrosine 77 (Y71 in Ras proteins) and this modification stabilises the active state, as shown by molecular dynamics (MD) simulation [27]. As suggested by Sun et al., this tyrosine is also very important for Ras to interact with ligands, as the phenolic side chain has to change its position in order to create a cavity suitable for ligand binding [6]. It is believed that the nucleotide binding state of the Ras protein controls the positioning of the switches. Further, MD simulations suggested, that the 3D orientation of the Switch II is directly affected by the interplay between G60 and γ-phosphate [28]. Our data presented here now show that this mechanism apparently works either way: Through direct binding, bisphenols can change the positioning of the Switch II and allosterically alter the positioning of the p-loop and other residues, including T35 and G60. In vivo, this leads to activation of the Ras signalling cascade, as shown by raised pERK and pAKT levels. Our results presented here therefore show that bisphenols not only bind to Ras isoforms but can also activate Ras signalling cascades. Hence, in vivo toxicity analyses of bisphenols using preclinical tumor models will be of major interest for pathophysiological exposure studies. Presumably, this will also be beneficial for the pharmaceutical development of GTPase-selective antagonists for cancer treatment [5,6,9,10].

4. Materials and Methods

4.1. Protein Expression and Purification

15N-enriched K-Ras4B, H-Ras4A (p21), Rap1A comprising residues 1–170 were expressed in E. coli and purified, fully saturated with GDP, from cell lysate as previously published [9,10,13,17,18]. Expression and purification of 15N-enriched N-Ras and 14N SOScat protein were also carried out as already published [9,10,17,18,29].

4.2. Low Molecular Weight Compounds and Solvents

The following compounds were purchased from Sigma-Aldrich (St. Louis, MO, USA):
  • AFX (4-(Trifluoromethyl)phenol, CAS 402-45-9),
  • Bisphenol A (BPA, 2,2-Bis(4-hydroxyphenyl)propane, CAS 80-05-7),
  • Bisphenol AF (BPAF, 2,2-Bis(4-hydroxyphenyl)hexafluoropropane, CAS 1478-61-1),
  • Bisphenol AP (BPAP, 4,4′-(1-Phenylethylidene)bisphenol, CAS 571-75-1),
  • Bisphenol BP (BPBP, Bis(4-hydroxyphenyl)diphenylmethane, CAS 1844-01-5),
  • Bisphenol C (BPC, 2,2-Bis(4-hydroxy-3-methylphenyl)propane, CAS 79-97-0),
  • Bisphenol FL (BPFL, 4,4′-(9-Fluorenylidene)diphenol, CAS 3236-71-3),
  • Bisphenol M (BPM, 4,4′-(1,3-Phenylenediisopropylidene)bisphenol, CAS 13595-25-0),
  • Bisphenol NH2 (BPNH2, 2,2-Bis(3-amino-4-hydroxyphenyl)hexafluoropropane, CAS 83558-87-6),
  • Bisphenol P (BPP, 4,4′-(1,4-Phenylenediisopropylidene)bisphenol, CAS 2167-51-3),
  • Bisphenol S (BPS, 4,4′-Sulfonyldiphenol, CAS 80-09-1),
  • Bisphenol Z (BPZ, 4,4′-Cyclohexylidenebisphenol, CAS 843-55-0)
Deuterated solvents for NMR measurements were obtained from Deutero GmbH (Kastellaun, Germany) and the following compounds were purchased from TCI Germany (Eschborn, Germany):
  • Bisphenol B (BPB, 2,2-Bis(4-hydroxyphenyl)butane, CAS 77-40-7),
  • Bisphenol E (BPE, 1,1-Bis(4-hydroxyphenyl)ethane, CAS 2081 08 5),
  • Bisphenol F (BPF, 4,4′-Methylenediphenol, CAS 620-92-8)
4-(Trifluoromethyl)phenol (AFX) was used as a control compound that bears a single phenolic ring system. Although AFX exhibits a rather low affinity towards K-Ras4B, it causes chemical shift perturbations for L6, I55, L56, T74, and G75, similar to bisphenols BPA and BPS. We designate these amino acids as “first-ring”-residues as they cluster on the surface of K-Ras4B and constitute a defined ligand binding site for bisphenols (Figure 1).

4.3. NMR Spectroscopy

The NMR titration experiments, resonance assignments, and data handling were performed as previously published [9]. Spectra were acquired on Bruker DRX 600 and AVANCE III HD 700 spectrometers, except for 19F NMR spectra that were recorded on a Bruker DPX 250 spectrometer at 235 MHz. The reference experiment for the competitive titration of 14N SOScat and BPAF to 15N-enriched GDP-bound K-Ras4B was acquired in the presence of 0.2 mM BPAF in PBS at pH 7.4. Upon titration of 14N SOScat to a 0.4 mM sample of GDP-bound 15N-enriched K-Ras4B, line broadening and/or disappearance of NMR resonances for GDP-loaded K-Ras4B bound to SOScat is observed probably due to rotational correlation effects of the approx. 80 kDa protein-protein complex. Line broadening can already be detected in 2D 1H-15N HSQC spectra of 14N SOScat:15N-enriched GDP-bound K-Ras4B at a molar ratio of 1:1, and this effect is more pronounced when extra SOScat is added to adjust a molar ratio of 1:2. Addition of an increasing amount of BPAF to the 1:2 15N-enriched K-Ras4B/14N SOScat complex (1:2:0.5, 1:2:1, 1:2:4) recovers the backbone amide proton NMR resonances in 2D 1H-15N HSQC spectra. The acquired NMR spectrum is similar to the 15N-enriched GDP-bound K-Ras4B:BPAF 1H-15N HSQC spectrum.

4.4. Molecular Modelling

HADDOCK 2- and CNS 1.2-based molecular docking of bisphenols on the RCSB set of coordinates 4DSO was performed as reported previously [5,9,10,15]. The following active ambiguous interaction restraints (AIRs) were selected: L6, I55, L56, D57, T74, and G75 for AFX, BPF, BPE, and BPA; L6, L56, D57, M72, T74, and G75 for BPB; E37, S39, L56, M67, T74, G75 for the sulphonyl moiety containing bisphenol analogue; L6, I24, L56, D57, T74, G75 for BPAF; L6, I24, L56, M72, T74, and G75 for BPNH2. For all BPs, the following solvent buffer exposed amino acids were chosen as passive AIRs, which encircle residues used as active AIRs: T3, K5, I36, E37, D38, S39, Y40, R41, L52, D54, D69, Q70, R73, E76, K104, if not already set as active AIR. PyMol (Delano, W. L., The PyMol Molecular Graphics System (2002) Delano Scientific, Palo Alto, CA, USA) was used for visualisation and analysis of molecular structures.

4.5. SOScat-Mediated Nucleotide Exchange Assay and GDI Assay

The SOScat assay was performed as described [9]. Briefly, a solution of 1 µM Ras*mantGDP, 200 µM GDP was mixed with different concentrations of BPNH2 and incubated at 20 °C for 5–10 min. To prevent insolubility of the BPNH2, 5% v/v DMSO was applied. After adding 0.5 µM of SOScat, a fluorescence spectrum was recorded with a Perkin Elmer LS50B instrument applying an excitation wavelength of 366 nm and an emission wavelength of 442 nm. The kobs value describing the dissociation rate of the nucleotide is obtained for each BPNH2 concentration from a single exponential fit to the fluorescence time course. The GDI (guanine nucleotide dissociation inhibitor) assay is carried out similar to the SOScat assay: Instead of mantGDP, the non-hydrolysable GTP analogue mantGppNHp is used but no SOScat is added here [17,18]. Again, the dissociation of the fluorescent nucleotide from Ras in the presence of various BPNH2 concentrations is detected by the decrease of fluorescence and the time dependence yields the kobs values. A plot of the kobs values versus BPNH2 concentration fitted by a binding isotherm yields the KD value of the BPNH2 complex (Figure 4 and Figure S7).

4.6. MTT Cytotoxicity Assay

Hela cells were used to determine IC50 values for different bisphenols. Therefore cells (1100 cells/well) were seeded in 96 well plates. 24 h after seeding cells were treated with individual bisphenols or corresponding DMSO in indicated concentrations up to 72 h. Subsequently, 10 μL of a MTT stock solution (5 mg/mL) were added to each well for 4 h. The mixture was removed carefully via pipetting, and the remaining formazan crystals formed were dissolved by 100 μL DMSO/10% SDS/0.01 M acetic acid for 15 min. The absorbance (570 nm and reference 620 nm) was determined using an absorbance reader and blank values were subtracted. Prism 6 (GraphPad Software, La Jolla, CA, USA) was used to calculate IC50 values.

4.7. G-LISA Ras Activation Assay

G-LISA Ras activation assay was performed as described before [30]. Briefly, HEK293T cells were seeded in 10-cm dishes followed by overnight incubation and afterwards serum-starved for 16 h. Cells were then treated with individual bisphenols (BPAF [20 µM] and BPNH2 [33 µM]) or DMSO (control, Ctrl) in a time-dependent manner (1, 2, 4 h), subsequently lysed and the protein concentration was determined using Precision RedTM Advanced Protein Assay Reagent. Quantitative analysis of active Ras was performed with a G-LISA Ras activation assay (Cytoskeleton, Inc., Denver CO, USA) using 1 mg/mL of the sample. The signal intensity was determined by measuring absorbance at 490 nm using a microplate spectrophotometer. Additionally, these lysates were subjected to western blot analysis in order to determine the activation of ERK and AKT signalling. To test for statistical significance, a two-tailed Student’s t-test was applied using Prism version 5.0 (GraphPad Software, La Jolla, CA, USA).

5. Conclusions

Small GTPases constitute a family of proteins that can govern cellular processes by acting as binary on/off switches. Bisphenols are widely used as industrial plasticisers in polycarbonate plastics and can thus be found in many household products of modern life. Here, we present the first extensive study of how small GTPases, in particular H-Ras, N-Ras, and K-Ras isoforms as well as Rap-1A, interact with bisphenols BPA, BPAF, BPB, BPE, BPF, and BPNH2. We could show that bisphenols bind selectivity to a subset of small GTPases and induce an active conformation. Not only could we determine their KD values, but we also show that these bisphenolic ligands selectively interact with all Ras isoforms except for Rap-1A. Bisphenols, in particular BPNH2, can utilise a common site on Ras proteins and allosterically induce their respective active conformations while still bound to GDP. In summary, we show here that Ras isoforms are off-target proteins for bisphenols and that they can act as their agonists. They should thus be considered in future toxicity evaluations of bisphenols and they might also serve as a blueprint for new Ras agonists or even antagonists.

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/1422-0067/19/4/1133/s1.

Acknowledgments

We are grateful to the Deutsche Krebshilfe e. V. (109776 and 109777), the DFG (SFB 642 A6, INST 213/757-1 FUGG), and the RUB Research SchoolPlus for generous financial support. We acknowledge support by the DFG Open Access Publication Funds of the Ruhr University of Bochum.

Author Contributions

Miriam Schöpel, Iris Helfrich, Hagen S. Bachmann, Xueyin Zhong, Jürgen Scherkenbeck, Christian Herrmann, and Raphael Stoll, conceived and designed the experiments; Miriam Schöpel, Oleksandr Shkura, Jana Seidel, Jürgen Scherkenbeck, Klaus Kock, Stefanie Löffek, and Hagen S. Bachmann, performed the experiments; Miriam Schöpel, Oleksandr Shkura, Jana Seidel, Klaus Kock, Xueyin Zhong, Jürgen Scherkenbeck, Stefanie Löffek, Hagen S. Bachmann, Christian Herrmann, and Raphael Stoll analysed the data; Miriam Schöpel, Oleksandr Shkura, and Raphael Stoll wrote the paper.

Conflicts of Interest

The authors declare no conflict of interest. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.

Abbreviations

GDPGuanosine Diphosphate
GTPGuanosine Triphosphate
SOSSon of Sevenless
SARStructure-Activity-Relationship
GDIGuanine Nucleotide Dissociation
NMRNuclear Magnetic Resonance
CSPChemical Shift Perturbation

References

  1. Vetter, I.R.; Wittinghofer, A. The guanine nucleotide-binding switch in three dimensions. Science 2001, 294, 1299–1304. [Google Scholar] [CrossRef] [PubMed]
  2. Schubbert, S.; Shannon, K.; Bollag, G. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 2007, 7, 295–308. [Google Scholar] [CrossRef]
  3. Simon, M.A.; Bowtell, D.D.L.; Dodson, G.S.; Laverty, T.R.; Rubin, G.M. Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase. Cell 1991, 67, 701–716. [Google Scholar] [CrossRef]
  4. Sharma, A.; Luke, C.T.; Dower, N.A.; Stone, J.C.; Lorenzo, P.S. RasGRP1 is essential for Ras activation by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate in epidermal keratinocytes. J. Biol. Chem. 2010, 285, 15724–15730. [Google Scholar] [CrossRef]
  5. Maurer, T.; Garrenton, L.S.; Oh, A.; Pitts, K.; Anderson, D.J.; Skelton, N.J. Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity. Proc. Natl. Acad. Sci. USA 2012, 109, 5299–5304. [Google Scholar] [CrossRef] [PubMed]
  6. Sun, Q.; Burke, J.P.; Phan, J.; Burns, M.C.; Olejniczak, E.T.; Waterson, A.G.; Lee, T.; Rossanese, O.W.; Fesik, S.W. Discovery of small molecules that bind to K-Ras and inhibit SOS-mediated activation **. Angew. Chem. 2012, 51, 6140–6143. [Google Scholar] [CrossRef] [PubMed]
  7. Welsch, M.E.; Kaplan, A.; Chambers, J.M.; Olive, K.P.; Ferrando, A.; Stockwell, B.R.; Sanchez-martin, M.; Badgley, M.A.; Huang, C.S.; Tran, T.H.; et al. Multivalent small-molecule Pan-RAS inhibitors. Cell 2017, 168, 878–889. [Google Scholar] [CrossRef] [PubMed]
  8. Erlanson, D.A.; Fesik, S.W.; Hubbard, R.E.; Jahnke, W.; Jhoti, H. Twenty years on: The impact of fragments on drug discovery. Nat. Rev. Drug Discov. 2016, 15, 605–619. [Google Scholar] [CrossRef] [PubMed]
  9. Schöpel, M.; Jockers, K.F.G.; Düppe, P.M.; Autzen, J.; Potheraveedu, V.N.; Ince, S.; Yip, K.T.; Heumann, R.; Herrmann, C.; Scherkenbeck, J.; et al. Bisphenol A binds to Ras proteins and competes with guanine nucleotide exchange: Implications for GTPase-selective antagonists. J. Med. Chem. 2013, 56, 9664–9672. [Google Scholar] [CrossRef] [PubMed]
  10. Schöpel, M.; Herrmann, C.; Scherkenbeck, J.; Stoll, R. The Bisphenol A analogue Bisphenol S binds to K-Ras4B—Implications for “BPA-free” plastics. FEBS Lett. 2016, 590, 369–375. [Google Scholar] [CrossRef] [PubMed]
  11. Liu, J.; Martin, J.W. Prolonged exposure to Bisphenol A from single dermal contact events. Environ. Sci. Technol. 2017, 51, 9940–9949. [Google Scholar] [CrossRef] [PubMed]
  12. Cromm, P.M.; Spiegel, J.; Grossmann, T.N.; Waldmann, H. Direct modulation of small GTPase activity and function. Angew. Chem. Int. Ed. 2015, 54, 13516–13537. [Google Scholar] [CrossRef] [PubMed]
  13. Sun, Q.; Phan, J.; Friberg, A.R.; Camper, D.V.; Olejniczak, E.T.; Fesik, S.W. A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand. J. Biomol. NMR 2014, 60, 11–14. [Google Scholar] [CrossRef] [PubMed]
  14. Zhou, P.; Zou, J.; Tian, F.; Shang, Z. Fluorine bonding--how does it work in protein-ligand interactions? J. Chem. Inf. Model. 2009, 49, 2344–2355. [Google Scholar] [CrossRef] [PubMed]
  15. Dominguez, C.; Boelens, R.; Bonvin, A.M.J.J. HADDOCK: A protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 2003, 125, 1731–1737. [Google Scholar] [CrossRef] [PubMed]
  16. Boriack-Sjodin, P.A.; Margarit, S.M.; Bar-Sagi, D.; Kuriyan, J. The structural basis of the activation of Ras by SOS. Nature 1998, 394, 337–343. [Google Scholar] [CrossRef] [PubMed]
  17. Nassar, N.; Horn, G.; Herrmann, C.; Block, C.; Janknecht, R.; Wittinghofer, A. Ras/Rap effector specificity determined by charge reversal. Nat. Struct. Biol. 1996, 3, 723–729. [Google Scholar] [CrossRef] [PubMed]
  18. Herrmann, C.; Horn, G.; Spaargaren, M.; Wittinghofer, A.; Herrmann, C.; Spaargaren, M.; Wittinghofer, A. Differential interaction of the Ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the Putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor. J. Biol. Chem. 1996, 271, 6794–6800. [Google Scholar] [CrossRef] [PubMed]
  19. Wittinghofer, A.; Vetter, I.R. Structure-function relationships of the G domain, a canonical switch motif. Annu. Rev. Biochem. 2011, 80, 943–971. [Google Scholar] [CrossRef] [PubMed]
  20. Herrmann, C.; Martin, G.A.; Wittinghofer, A. Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase. J. Biol. Chem. 1995, 270, 2901–2905. [Google Scholar] [CrossRef] [PubMed]
  21. Kubinyi, H. Hydrogen bonding: The last mystery in drug design? Pharmacokinet. Optim. Drug Res. 2001, 513–524. [Google Scholar] [CrossRef]
  22. Smith, M.J.; Neel, B.G.; Ikura, M. NMR-based functional profiling of RASopathies and oncogenic RAS mutations. Proc. Natl. Acad. Sci. USA 2013, 110, 4574–4579. [Google Scholar] [CrossRef] [PubMed]
  23. Rosnizeck, I.C.; Graf, T.; Spoerner, M.; Tränkle, J.; Filchtinski, D.; Herrmann, C.; Gremer, L.; Vetter, I.R.; Wittinghofer, A.; König, B.; et al. Stabilizing a weak binding state for effectors in the human ras protein by cyclen complexes. Angew. Chem. Int. Ed. 2010, 49, 3830–3833. [Google Scholar] [CrossRef] [PubMed]
  24. Ito, Y.; Yamasaki, K.; Iwahara, J.; Terada, T.; Kamiya, A.; Shirouzu, M.; Muto, Y.; Kawai, G.; Yokoyama, S.; Laue, E.D.; et al. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein. Biochemistry 1997, 36, 9109–9119. [Google Scholar] [CrossRef] [PubMed]
  25. Ehrkamp, A.; Herrmann, C.; Stoll, R.; Heumann, R. Ras and rheb signaling in survival and cell death. Cancers 2013, 5, 639–661. [Google Scholar] [CrossRef] [PubMed]
  26. Müller, M.P.; Peters, H.; Blümer, J.; Blankenfeldt, W.; Goody, R.S.; Itzen, A. The Legionella effector protein DrrA AMPylates the membrane traffic regulator Rab1b. Science 2010, 329, 946–949. [Google Scholar] [CrossRef] [PubMed]
  27. Luitz, M.P.; Bomblies, R.; Ramcke, E.; Itzen, A.; Zacharias, M. Adenylylation of Tyr77 stabilizes Rab1b GTPase in an active state: A molecular dynamics simulation analysis. Sci. Rep. 2016, 6, 19896. [Google Scholar] [CrossRef] [PubMed]
  28. Kobayashi, C.; Saito, S. Relation between the conformational heterogeneity and reaction cycle of Ras: Molecular simulation of Ras. Biophys. J. 2010, 99, 3726–3734. [Google Scholar] [CrossRef] [PubMed]
  29. Tucker, J.; Sczakiel, G.; Feuerstein, J.; John, J.; Goody, R.S.; Wittinghofer, A. Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide-binding site. EMBO J. 1986, 5, 1351–1358. [Google Scholar] [PubMed]
  30. Löffek, S.; Hurskainen, T.; Jackow, J.; Sigloch, F.C.; Schilling, O.; Tasanen, K.; Bruckner-Tuderman, L.; Franzke, C.W. Transmembrane collagen XVII modulates integrin dependent keratinocyte migration via PI3K/Rac1 signaling. PLoS ONE 2014, 9. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Definition of the different binding clusters: the 1st (ligand) ring (L6, I55, L56, T74, G75), the buried hydrophobic cluster (L79, C80, I93), and the NBD (nucleotide binding cluster, D57 and G60), and their location within the GTPase fold.
Figure 1. Definition of the different binding clusters: the 1st (ligand) ring (L6, I55, L56, T74, G75), the buried hydrophobic cluster (L79, C80, I93), and the NBD (nucleotide binding cluster, D57 and G60), and their location within the GTPase fold.
Ijms 19 01133 g001
Figure 2. Competitive titration of 15N-enriched GDP-bound K-Ras4B with 14N SOScat and BPAF at 600 MHz and 298 K. Different 2D 1H-15N HSQC NMR spectra of this titration are shown, starting with the K-Ras4B GDP protein only (reference in black). In dark and lighter blue spectra with the GEF-protein SOScat added (molar ratios of 1:1 and 1:2) are depicted. The resulting line broadening of resonances is clearly visible. In green, the ligand BPAF is added in a molar ratio of 1:2:0.5. In orange and pink, the 1:2:2 and 1:2:4 molar ratio titration steps are shown. The recovery of backbone amide proton NMR resonances is indicated by dashed yellow circles. It is important to note that the recovered resonances of residues from the binding pocket exhibit chemical shift perturbations compared to ligand-free 2D 1H-15N HSQC spectra of 15N-enriched GDP-bound K-Ras4B that match those observed during the titration of GDP-bound K-Ras4B with BPAF alone.
Figure 2. Competitive titration of 15N-enriched GDP-bound K-Ras4B with 14N SOScat and BPAF at 600 MHz and 298 K. Different 2D 1H-15N HSQC NMR spectra of this titration are shown, starting with the K-Ras4B GDP protein only (reference in black). In dark and lighter blue spectra with the GEF-protein SOScat added (molar ratios of 1:1 and 1:2) are depicted. The resulting line broadening of resonances is clearly visible. In green, the ligand BPAF is added in a molar ratio of 1:2:0.5. In orange and pink, the 1:2:2 and 1:2:4 molar ratio titration steps are shown. The recovery of backbone amide proton NMR resonances is indicated by dashed yellow circles. It is important to note that the recovered resonances of residues from the binding pocket exhibit chemical shift perturbations compared to ligand-free 2D 1H-15N HSQC spectra of 15N-enriched GDP-bound K-Ras4B that match those observed during the titration of GDP-bound K-Ras4B with BPAF alone.
Ijms 19 01133 g002
Figure 3. Overall view of the NMR chemical shift perturbation observed for K-Ras4B bound to GDP upon titration with Bisphenol AF (upper panel) and BPNH2 (lower panel), ranging from the black reference to a ratio of 1:25, shown in magenta. The enlarged panels illustrate residues G60, T74, and G75. The titrations were performed as previously published [9]. In order to decrease solubility artefacts, the different ligands were titrated in the same % v/v steps, using different stock concentrations.
Figure 3. Overall view of the NMR chemical shift perturbation observed for K-Ras4B bound to GDP upon titration with Bisphenol AF (upper panel) and BPNH2 (lower panel), ranging from the black reference to a ratio of 1:25, shown in magenta. The enlarged panels illustrate residues G60, T74, and G75. The titrations were performed as previously published [9]. In order to decrease solubility artefacts, the different ligands were titrated in the same % v/v steps, using different stock concentrations.
Ijms 19 01133 g003
Figure 4. The SOScat-assay is based on the exchange of mGDP to non-fluorescent GDP in the presence of Ras-GEF SOScat. The SOScat assay was performed as described [9]. The kobs value describing the dissociation rate of the nucleotide is obtained for each BPNH2 concentration from a single exponential fit to the fluorescence time course. By varying the concentration of BPNH2, a KD value of 0.20 ± 0.10 mM was determined (please also refer to Figure S7).
Figure 4. The SOScat-assay is based on the exchange of mGDP to non-fluorescent GDP in the presence of Ras-GEF SOScat. The SOScat assay was performed as described [9]. The kobs value describing the dissociation rate of the nucleotide is obtained for each BPNH2 concentration from a single exponential fit to the fluorescence time course. By varying the concentration of BPNH2, a KD value of 0.20 ± 0.10 mM was determined (please also refer to Figure S7).
Ijms 19 01133 g004
Figure 5. The upper left part shows NMR chemical shift perturbations observed for amide resonances of K-Ras4B bound to GDP upon titration with Bisphenol AF, ranging from the black reference to a ratio of 1:25, shown in magenta. The spectrum of K-Ras4B bound to GppNHp is shown in red. Amino acids of K-Ras4B bound to GDP whose proton-amide resonances experience chemical shift perturbations towards resonance frequencies of K-Ras4B bound to GppNHp upon binding of BPAF are highlighted by arrows. The enlarged panel particularly illustrates residues I24, G75, C118, S145, and T148. The upper right part of highlights all proton-amide resonances of K-Ras4B bound to GDP whose proton-amide resonances experience chemical shift perturbations towards resonance frequencies of K-Ras4B bound to GppNHp upon binding of BPAF. These chemical shift perturbations are projected onto a ribbon representation of K-Ras4B bound to GDP and are coloured in red. The switch I (Sw1) and II (Sw2) regions are shown in blue. The lower part shows a comparison of Y157 NMR resonances upon nucleotide loading (purple = GppNHp), and the addition of ligand (cyan = GppNHp+BPAF). Saturating K-Ras4B with different ligands leads to an allosteric activation of the GTPase, as judged from the resonance of Y157 upon titration with different bisphenolic ligands (orange = AFX, red = BPF, teal = BPE, pink = BPA, violet = BPB, blue = BPAF, green = BPNH2, light blue = BPS).
Figure 5. The upper left part shows NMR chemical shift perturbations observed for amide resonances of K-Ras4B bound to GDP upon titration with Bisphenol AF, ranging from the black reference to a ratio of 1:25, shown in magenta. The spectrum of K-Ras4B bound to GppNHp is shown in red. Amino acids of K-Ras4B bound to GDP whose proton-amide resonances experience chemical shift perturbations towards resonance frequencies of K-Ras4B bound to GppNHp upon binding of BPAF are highlighted by arrows. The enlarged panel particularly illustrates residues I24, G75, C118, S145, and T148. The upper right part of highlights all proton-amide resonances of K-Ras4B bound to GDP whose proton-amide resonances experience chemical shift perturbations towards resonance frequencies of K-Ras4B bound to GppNHp upon binding of BPAF. These chemical shift perturbations are projected onto a ribbon representation of K-Ras4B bound to GDP and are coloured in red. The switch I (Sw1) and II (Sw2) regions are shown in blue. The lower part shows a comparison of Y157 NMR resonances upon nucleotide loading (purple = GppNHp), and the addition of ligand (cyan = GppNHp+BPAF). Saturating K-Ras4B with different ligands leads to an allosteric activation of the GTPase, as judged from the resonance of Y157 upon titration with different bisphenolic ligands (orange = AFX, red = BPF, teal = BPE, pink = BPA, violet = BPB, blue = BPAF, green = BPNH2, light blue = BPS).
Ijms 19 01133 g005
Figure 6. Level of BPAF-induced activation reported in %. Serum-starved HEK293T cells were treated with DMSO (Ctrl), BPAF [20 µM] and BPNH2 [33 µM] in a time-dependent manner (1, 2 and 4 h). EGF-stimulation [10 ng/mL] was carried out for 10 min. Thereafter, cells were lysed and subjected for G-LISA Ras Activation Assay Biochem Kit shown in the upper left corner and to immunoblot analysis (for pERK/pAKT in relation to total ERK/AKT) shown on the right. The graph is presented as mean ± SEM (n = 2, each experiment was carried out in triplicate; * p < 0.05; *** p < 0.001). The quantification of the pERK versus total ERK ratio is shown in the lower left corner. To this end, serum-starved HEK293T cells were treated with DMSO (Ctrl) or BPAF [20 µM] for 4 h. Then, cells were lysed and subjected to immunoblot analysis (for pERK in relation to total ERK). Quantification is based on three independent experiments and is presented as mean ± SEM (* p < 0.05).
Figure 6. Level of BPAF-induced activation reported in %. Serum-starved HEK293T cells were treated with DMSO (Ctrl), BPAF [20 µM] and BPNH2 [33 µM] in a time-dependent manner (1, 2 and 4 h). EGF-stimulation [10 ng/mL] was carried out for 10 min. Thereafter, cells were lysed and subjected for G-LISA Ras Activation Assay Biochem Kit shown in the upper left corner and to immunoblot analysis (for pERK/pAKT in relation to total ERK/AKT) shown on the right. The graph is presented as mean ± SEM (n = 2, each experiment was carried out in triplicate; * p < 0.05; *** p < 0.001). The quantification of the pERK versus total ERK ratio is shown in the lower left corner. To this end, serum-starved HEK293T cells were treated with DMSO (Ctrl) or BPAF [20 µM] for 4 h. Then, cells were lysed and subjected to immunoblot analysis (for pERK in relation to total ERK). Quantification is based on three independent experiments and is presented as mean ± SEM (* p < 0.05).
Ijms 19 01133 g006
Table 1. Bisphenols tested in this NMR study, with varying bridging moieties at the central sp3-hybridised carbon atom. AFX was used to characterize the binding of one phenolic ring to K-Ras4B. ND stands for not determined.
Table 1. Bisphenols tested in this NMR study, with varying bridging moieties at the central sp3-hybridised carbon atom. AFX was used to characterize the binding of one phenolic ring to K-Ras4B. ND stands for not determined.
Bisphenols tested
AFX
Ijms 19 01133 i001
BPF
Ijms 19 01133 i002
BPE
Ijms 19 01133 i003
KD = NDKD = 14 ± 2 mMKD = 6.5 ± 0.7 mM
BPA
Ijms 19 01133 i004
BPB
Ijms 19 01133 i005
BPAF
Ijms 19 01133 i006
KD = 0.6 ± 0.2 mMKD = 3.6 ± 0.7 mMKD = 0.4 ± 0.1 mM
BPS
Ijms 19 01133 i007
BPNH2
Ijms 19 01133 i008
BPM/BPP
BPZ
BPAP
BPBP
BPFL
BPC
BPP
KD = 5.8 ± 0.7 mMKD = 0.4 ± 0.1 mMLow solubility

Share and Cite

MDPI and ACS Style

Schöpel, M.; Shkura, O.; Seidel, J.; Kock, K.; Zhong, X.; Löffek, S.; Helfrich, I.; Bachmann, H.S.; Scherkenbeck, J.; Herrmann, C.; et al. Allosteric Activation of GDP-Bound Ras Isoforms by Bisphenol Derivative Plasticisers. Int. J. Mol. Sci. 2018, 19, 1133. https://doi.org/10.3390/ijms19041133

AMA Style

Schöpel M, Shkura O, Seidel J, Kock K, Zhong X, Löffek S, Helfrich I, Bachmann HS, Scherkenbeck J, Herrmann C, et al. Allosteric Activation of GDP-Bound Ras Isoforms by Bisphenol Derivative Plasticisers. International Journal of Molecular Sciences. 2018; 19(4):1133. https://doi.org/10.3390/ijms19041133

Chicago/Turabian Style

Schöpel, Miriam, Oleksandr Shkura, Jana Seidel, Klaus Kock, Xueyin Zhong, Stefanie Löffek, Iris Helfrich, Hagen S. Bachmann, Jürgen Scherkenbeck, Christian Herrmann, and et al. 2018. "Allosteric Activation of GDP-Bound Ras Isoforms by Bisphenol Derivative Plasticisers" International Journal of Molecular Sciences 19, no. 4: 1133. https://doi.org/10.3390/ijms19041133

APA Style

Schöpel, M., Shkura, O., Seidel, J., Kock, K., Zhong, X., Löffek, S., Helfrich, I., Bachmann, H. S., Scherkenbeck, J., Herrmann, C., & Stoll, R. (2018). Allosteric Activation of GDP-Bound Ras Isoforms by Bisphenol Derivative Plasticisers. International Journal of Molecular Sciences, 19(4), 1133. https://doi.org/10.3390/ijms19041133

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop